First Time Loading...
S

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990

Watchlist Manager
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Watchlist
Price: 161.3 HKD -2.83%
Updated: May 29, 2024

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Operating Income
-¥453.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Income
-¥8.8B
CAGR 3-Years
8%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
-¥1.5B
CAGR 3-Years
-51%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
¥1.4B
CAGR 3-Years
22%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
¥8.7B
CAGR 3-Years
25%
CAGR 5-Years
34%
CAGR 10-Years
53%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Income
¥1.4B
CAGR 3-Years
59%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Operating Income?
Operating Income
-453.7m CNY

Based on the financial report for Dec 31, 2023, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Operating Income amounts to -453.7m CNY.

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 1Y
-18%

Over the last year, the Operating Income growth was -18%.